AB1428-HPR Fatigue in patients with quiescent systemic lupus erythematosus: The role of dehydroepiandrosterone sulfate
Background Fatigue is a major problem in systemic lupus erythematosus (SLE). In some patient groups, associations between fatigue and low levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) have been found. Low levels of DHEA(S) may also play a role in SLE fatigue. Objectives To compare...
Gespeichert in:
| Veröffentlicht in: | Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.756 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Suppl 3 |
| container_start_page | 756 |
| container_title | Annals of the rheumatic diseases |
| container_volume | 71 |
| creator | Overman, C.L. Hartkamp, A. Bossema, E.R. Bijl, M. Godaert, G.L.R. Bijlsma, J.W.J. Derksen, R.H.W. Geenen, R. |
| description | Background Fatigue is a major problem in systemic lupus erythematosus (SLE). In some patient groups, associations between fatigue and low levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) have been found. Low levels of DHEA(S) may also play a role in SLE fatigue. Objectives To compare 1) serum DHEAS levels and fatigue between female patients with quiescent SLE and healthy women, and 2) fatigue between SLE patients with low and normal DHEAS levels. Methods Included were 60 female patients with quiescent SLE (31 using prednisone and 29 not using prednisone) and 60 age-matched healthy women. Serum DHEAS levels were determined using an Advantage Chemiluminescense System. Fatigue was measured with the Multidimensional Fatigue Inventory (MFI). Groups were compared on DHEAS and fatigue using Chi2 and Mann-Whitney U tests. Results Compared to healthy women, SLE patients were more fatigued (p≤0.001) and more often had DHEAS levels below the lower limit of normal (p |
| doi_str_mv | 10.1136/annrheumdis-2012-eular.1420 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777972812</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008647301</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1652-a8ebc8755818909d961555a6ff8403c668e51c4ce8dc676d535dbe9ea66da27f3</originalsourceid><addsrcrecordid>eNqVkMlOwzAQhi0EEmV5B0ucA3YSL4ETVJRFCBCCcrTcZEJcsmHHgt648KI8CS5FiCun8Vjf7xl_CO1Rsk9pwg9029oKfFMYF8WExhH4Wtt9msZkDY1oymW45mQdjQghSZRmXGyiLefmoSWSyhF6Oz4JtIzOb-8-3z8mejBPHrBpcR-O0A4Ov5qhwi_egMtDj93CDdCYHNe-9w6DXQwVNHronHeH-L4CbLsacFfiAqpFYTvojW5DDTHbtYCdr0s9wA7aKHXtYPenbqOHyen9-Dy6ujm7GB9fRTPKWRxpCbNcCsbCthnJioxTxpjmZSlTkuScS2A0T3OQRc4FL1jCihlkoDkvdCzKZBvtrd7tbffiwQ1q3nnbhpGKCiEyEUsaB-poReVhUWehVL01jbYLRYlaqlZ_VKulavWtWi1Vh3S0SpvwybffqLbPiotEMHU9HavLJDubkilXj4HnK37WzP816AuwBZxQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777972812</pqid></control><display><type>article</type><title>AB1428-HPR Fatigue in patients with quiescent systemic lupus erythematosus: The role of dehydroepiandrosterone sulfate</title><source>BMJ Journals - NESLi2</source><creator>Overman, C.L. ; Hartkamp, A. ; Bossema, E.R. ; Bijl, M. ; Godaert, G.L.R. ; Bijlsma, J.W.J. ; Derksen, R.H.W. ; Geenen, R.</creator><creatorcontrib>Overman, C.L. ; Hartkamp, A. ; Bossema, E.R. ; Bijl, M. ; Godaert, G.L.R. ; Bijlsma, J.W.J. ; Derksen, R.H.W. ; Geenen, R.</creatorcontrib><description>Background Fatigue is a major problem in systemic lupus erythematosus (SLE). In some patient groups, associations between fatigue and low levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) have been found. Low levels of DHEA(S) may also play a role in SLE fatigue. Objectives To compare 1) serum DHEAS levels and fatigue between female patients with quiescent SLE and healthy women, and 2) fatigue between SLE patients with low and normal DHEAS levels. Methods Included were 60 female patients with quiescent SLE (31 using prednisone and 29 not using prednisone) and 60 age-matched healthy women. Serum DHEAS levels were determined using an Advantage Chemiluminescense System. Fatigue was measured with the Multidimensional Fatigue Inventory (MFI). Groups were compared on DHEAS and fatigue using Chi2 and Mann-Whitney U tests. Results Compared to healthy women, SLE patients were more fatigued (p≤0.001) and more often had DHEAS levels below the lower limit of normal (p<0.001), in particular those using prednisone. Compared to SLE patients with normal DHEAS levels, patients not using prednisone reported less fatigue on four out of five fatigue dimensions (p≤0.03). SLE patients using prednisone with low and normal DHEAS levels reported a similar level of fatigue (p≥0.39). Conclusions Although in patients with quiescent SLE low serum DHEAS levels are more frequent and fatigue levels are higher than in healthy people, low DHEAS levels are not - or even inversely - related to fatigue. After our previous finding that DHEA administration does not reduce fatigue, this result further indicates that low DHEA(S) levels alone do not offer an explanation for SLE fatigue. Disclosure of Interest None Declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2012-eular.1420</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><ispartof>Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.756</ispartof><rights>2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/71/Suppl_3/756.10.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/71/Suppl_3/756.10.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3183,23550,27901,27902,77569,77600</link.rule.ids></links><search><creatorcontrib>Overman, C.L.</creatorcontrib><creatorcontrib>Hartkamp, A.</creatorcontrib><creatorcontrib>Bossema, E.R.</creatorcontrib><creatorcontrib>Bijl, M.</creatorcontrib><creatorcontrib>Godaert, G.L.R.</creatorcontrib><creatorcontrib>Bijlsma, J.W.J.</creatorcontrib><creatorcontrib>Derksen, R.H.W.</creatorcontrib><creatorcontrib>Geenen, R.</creatorcontrib><title>AB1428-HPR Fatigue in patients with quiescent systemic lupus erythematosus: The role of dehydroepiandrosterone sulfate</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Background Fatigue is a major problem in systemic lupus erythematosus (SLE). In some patient groups, associations between fatigue and low levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) have been found. Low levels of DHEA(S) may also play a role in SLE fatigue. Objectives To compare 1) serum DHEAS levels and fatigue between female patients with quiescent SLE and healthy women, and 2) fatigue between SLE patients with low and normal DHEAS levels. Methods Included were 60 female patients with quiescent SLE (31 using prednisone and 29 not using prednisone) and 60 age-matched healthy women. Serum DHEAS levels were determined using an Advantage Chemiluminescense System. Fatigue was measured with the Multidimensional Fatigue Inventory (MFI). Groups were compared on DHEAS and fatigue using Chi2 and Mann-Whitney U tests. Results Compared to healthy women, SLE patients were more fatigued (p≤0.001) and more often had DHEAS levels below the lower limit of normal (p<0.001), in particular those using prednisone. Compared to SLE patients with normal DHEAS levels, patients not using prednisone reported less fatigue on four out of five fatigue dimensions (p≤0.03). SLE patients using prednisone with low and normal DHEAS levels reported a similar level of fatigue (p≥0.39). Conclusions Although in patients with quiescent SLE low serum DHEAS levels are more frequent and fatigue levels are higher than in healthy people, low DHEAS levels are not - or even inversely - related to fatigue. After our previous finding that DHEA administration does not reduce fatigue, this result further indicates that low DHEA(S) levels alone do not offer an explanation for SLE fatigue. Disclosure of Interest None Declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqVkMlOwzAQhi0EEmV5B0ucA3YSL4ETVJRFCBCCcrTcZEJcsmHHgt648KI8CS5FiCun8Vjf7xl_CO1Rsk9pwg9029oKfFMYF8WExhH4Wtt9msZkDY1oymW45mQdjQghSZRmXGyiLefmoSWSyhF6Oz4JtIzOb-8-3z8mejBPHrBpcR-O0A4Ov5qhwi_egMtDj93CDdCYHNe-9w6DXQwVNHronHeH-L4CbLsacFfiAqpFYTvojW5DDTHbtYCdr0s9wA7aKHXtYPenbqOHyen9-Dy6ujm7GB9fRTPKWRxpCbNcCsbCthnJioxTxpjmZSlTkuScS2A0T3OQRc4FL1jCihlkoDkvdCzKZBvtrd7tbffiwQ1q3nnbhpGKCiEyEUsaB-poReVhUWehVL01jbYLRYlaqlZ_VKulavWtWi1Vh3S0SpvwybffqLbPiotEMHU9HavLJDubkilXj4HnK37WzP816AuwBZxQ</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Overman, C.L.</creator><creator>Hartkamp, A.</creator><creator>Bossema, E.R.</creator><creator>Bijl, M.</creator><creator>Godaert, G.L.R.</creator><creator>Bijlsma, J.W.J.</creator><creator>Derksen, R.H.W.</creator><creator>Geenen, R.</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20130601</creationdate><title>AB1428-HPR Fatigue in patients with quiescent systemic lupus erythematosus: The role of dehydroepiandrosterone sulfate</title><author>Overman, C.L. ; Hartkamp, A. ; Bossema, E.R. ; Bijl, M. ; Godaert, G.L.R. ; Bijlsma, J.W.J. ; Derksen, R.H.W. ; Geenen, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1652-a8ebc8755818909d961555a6ff8403c668e51c4ce8dc676d535dbe9ea66da27f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Overman, C.L.</creatorcontrib><creatorcontrib>Hartkamp, A.</creatorcontrib><creatorcontrib>Bossema, E.R.</creatorcontrib><creatorcontrib>Bijl, M.</creatorcontrib><creatorcontrib>Godaert, G.L.R.</creatorcontrib><creatorcontrib>Bijlsma, J.W.J.</creatorcontrib><creatorcontrib>Derksen, R.H.W.</creatorcontrib><creatorcontrib>Geenen, R.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Overman, C.L.</au><au>Hartkamp, A.</au><au>Bossema, E.R.</au><au>Bijl, M.</au><au>Godaert, G.L.R.</au><au>Bijlsma, J.W.J.</au><au>Derksen, R.H.W.</au><au>Geenen, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AB1428-HPR Fatigue in patients with quiescent systemic lupus erythematosus: The role of dehydroepiandrosterone sulfate</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2013-06-01</date><risdate>2013</risdate><volume>71</volume><issue>Suppl 3</issue><spage>756</spage><pages>756-</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background Fatigue is a major problem in systemic lupus erythematosus (SLE). In some patient groups, associations between fatigue and low levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) have been found. Low levels of DHEA(S) may also play a role in SLE fatigue. Objectives To compare 1) serum DHEAS levels and fatigue between female patients with quiescent SLE and healthy women, and 2) fatigue between SLE patients with low and normal DHEAS levels. Methods Included were 60 female patients with quiescent SLE (31 using prednisone and 29 not using prednisone) and 60 age-matched healthy women. Serum DHEAS levels were determined using an Advantage Chemiluminescense System. Fatigue was measured with the Multidimensional Fatigue Inventory (MFI). Groups were compared on DHEAS and fatigue using Chi2 and Mann-Whitney U tests. Results Compared to healthy women, SLE patients were more fatigued (p≤0.001) and more often had DHEAS levels below the lower limit of normal (p<0.001), in particular those using prednisone. Compared to SLE patients with normal DHEAS levels, patients not using prednisone reported less fatigue on four out of five fatigue dimensions (p≤0.03). SLE patients using prednisone with low and normal DHEAS levels reported a similar level of fatigue (p≥0.39). Conclusions Although in patients with quiescent SLE low serum DHEAS levels are more frequent and fatigue levels are higher than in healthy people, low DHEAS levels are not - or even inversely - related to fatigue. After our previous finding that DHEA administration does not reduce fatigue, this result further indicates that low DHEA(S) levels alone do not offer an explanation for SLE fatigue. Disclosure of Interest None Declared</abstract><cop>Kidlington</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/annrheumdis-2012-eular.1420</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-4967 |
| ispartof | Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.756 |
| issn | 0003-4967 1468-2060 |
| language | eng |
| recordid | cdi_proquest_journals_1777972812 |
| source | BMJ Journals - NESLi2 |
| title | AB1428-HPR Fatigue in patients with quiescent systemic lupus erythematosus: The role of dehydroepiandrosterone sulfate |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T11%3A59%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AB1428-HPR%E2%80%85Fatigue%20in%20patients%20with%20quiescent%20systemic%20lupus%20erythematosus:%20The%20role%20of%20dehydroepiandrosterone%20sulfate&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Overman,%20C.L.&rft.date=2013-06-01&rft.volume=71&rft.issue=Suppl%203&rft.spage=756&rft.pages=756-&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2012-eular.1420&rft_dat=%3Cproquest_cross%3E4008647301%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777972812&rft_id=info:pmid/&rfr_iscdi=true |